Appeals court overturns triple damages in Zimmer Biomet’s $280M patent loss to Stryker

Appeals court overturns triple damages in Zimmer Biomet’s $280m patent loss to Stryker (MassDevice)
A federal appeals court today overturned the enhanced damages and attorney fees awarded in Stryker‘s (NYSE:SYK) $70 million patent infringement win over Zimmer Biomet (NYSE:ZBH), but upheld its prior ruling that patents were valid and infringed.
The case was sent back to the U.S. Court of Appeals for the Federal Circuit in June, when the Supreme Court held that the standard for enhanced damages awards in patent infringement cases should be relaxed. The case dates back to December 2010, when Stry...